TaiMed Biologics (4147) — Tangible Net Worth Ratio
TaiMed Biologics (4147) has a Tangible Net Worth Ratio of 88.5% as of December 2025. This metric is calculated by deducting intangible assets (NT$442.15 Million) from net assets (NT$3.86 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See TaiMed Biologics working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
TaiMed Biologics Tangible Net Worth Ratio (2009–2025)
This chart shows how TaiMed Biologics's Tangible Net Worth Ratio has changed across 17 annual periods from 2009 to 2025. As of December 2025, the ratio stands at 88.5%, reflecting net assets of NT$3.86 Billion with intangible assets of NT$442.15 Million TWD. See TaiMed Biologics (4147) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for TaiMed Biologics (2009–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for TaiMed Biologics from 2009 to 2025, covering 17 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see TaiMed Biologics market capitalisation.
| Year | Tangible NW Ratio | Net Assets (TWD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 88.5% | NT$3.86 Billion | NT$442.15 Million | NT$4.81 Billion | ▲ +1.9 pp |
| 2024 | 86.6% | NT$4.02 Billion | NT$539.40 Million | NT$5.00 Billion | ▲ +11.0 pp |
| 2023 | 75.6% | NT$2.57 Billion | NT$625.79 Million | NT$3.89 Billion | ▲ +2.3 pp |
| 2022 | 73.3% | NT$2.71 Billion | NT$724.38 Million | NT$4.10 Billion | ▲ +1.2 pp |
| 2021 | 72.1% | NT$2.94 Billion | NT$821.33 Million | NT$4.61 Billion | ▼ -0.4 pp |
| 2020 | 72.5% | NT$3.42 Billion | NT$940.16 Million | NT$5.20 Billion | ▼ -6.9 pp |
| 2019 | 79.4% | NT$3.59 Billion | NT$739.45 Million | NT$4.73 Billion | ▼ -4.9 pp |
| 2018 | 84.3% | NT$4.08 Billion | NT$642.28 Million | NT$4.79 Billion | ▼ -7.6 pp |
| 2017 | 91.9% | NT$4.29 Billion | NT$349.55 Million | NT$4.50 Billion | ▼ -1.0 pp |
| 2016 | 92.9% | NT$4.71 Billion | NT$336.57 Million | NT$4.80 Billion | ▼ -0.3 pp |
| 2015 | 93.2% | NT$4.90 Billion | NT$333.34 Million | NT$4.93 Billion | ▲ +11.4 pp |
| 2014 | 81.8% | NT$1.83 Billion | NT$333.34 Million | NT$1.88 Billion | ▲ +32.7 pp |
| 2013 | 49.1% | NT$657.73 Million | NT$334.83 Million | NT$714.72 Million | ▼ -36.0 pp |
| 2012 | 85.1% | NT$645.21 Million | NT$96.08 Million | NT$659.45 Million | ▲ +2.0 pp |
| 2011 | 83.1% | NT$839.24 Million | NT$141.74 Million | NT$854.39 Million | ▲ +0.4 pp |
| 2010 | 82.7% | NT$1.04 Billion | NT$179.83 Million | NT$1.06 Billion | ▲ +20.3 pp |
| 2009 | 62.4% | NT$598.14 Million | NT$224.79 Million | NT$617.22 Million | — |